Skip to content

comparing pain relief between 2 different eye injections in pediatric eye tumour surgeries

Comparison of peribulbar block and sub-tenon infiltration in paediatric enucleation of the eye

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011579
Enrollment
60
Registered
2018-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- stable patients with ocular tumour

Interventions

Intervention1: peribulbar block and subtenon infiltration: 0.3ml/kg of a 1:1 mixture of 0.5%Bupivacaine and 2% lignocaine with 5mcg/ml hyalase . Intervention2: subtenon infiltration: received 0.3ml/kg

Sponsors

AIIMS HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age ranging from 6months to 6 years ASA Grade I and II

Exclusion criteria

Exclusion criteria: Children whose parents are unwilling to give consent. ASA Grade III and IV Children who are mentally retarded or deaf. Children with a history of allergy to local anaesthetics. Significant cardiac, respiratory, hepatic or renal dysfunction. Children with any other intraocular pathology like endophthalmitis or in�ammatory diseases

Design outcomes

Primary

MeasureTime frame
Perioperative analgesia following enucleation surgeries in childrenTimepoint: All children were assessed immediately after surgery then after 1hr, 2hr,3hr,4hr,8hr and 24 hr

Secondary

MeasureTime frame
Recovery profile :Time to discharge from PACU (post anesthesia care unit) Incidence of Side effects : PONV and OCR Timepoint: In the postoperative period, all children were assessed immediately then after 1hr, 2hr,3hr,4hr,8hr and 24 hr

Countries

India

Contacts

Public ContactProf Dilip R Shende

All India Institute Of Medical Sciences

dilipshende@gmail.com8800377697

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026